Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful
Open Access
- 5 May 2009
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation
- Vol. 119 (17) , 2383-2395
Abstract
A dvanced lipoprotein testing and subfractionation have been used for scientific medical investigations in humans for Ͼ50 years. Original work from the Framingham Heart Study and the Lawrence Livermore Study, which was conducted at the University of California, first suggested the clinical utility of such advanced testing and provided the groundwork for future research. In the subsequent Ͼ50 years, clinical trials have documented that aspects of these tests contribute insight into the atherogenic process that is independent of standard lipid test results. Multiple lifestyle and pharmacological treatment studies have been conducted that reveal significant differences in response to treatment based on lipoprotein subclass classification. These changes in lipoprotein subclass distribution have been linked to differences in arteriographic outcome. Standard tests of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) misidentify coronary heart disease (CHD) risk status in a substantial portion of the population. Tests of apolipoprotein concentrations are superior to standard LDL-C tests, and it can be argued that they should replace standard lipoprotein cholesterol testing. Advanced lipoprotein tests that were previously available only from university research laboratories are now provided by several commercial laboratories. Although clinical utility has been demonstrated, on the basis of research laboratory quality tests, caution is advised relative to quality control issues and commercial laboratory testing.Keywords
This publication has 84 references indexed in Scilit:
- Relation of gemfibrozil treatment and high-density lipoprotein subpopulation profile with cardiovascular events in the Veterans Affairs High-Density Lipoprotein Intervention TrialMetabolism, 2008
- apoB/apoA–I ratio is related to femoral artery plaques and is predictive for future cardiovascular events in healthy menAtherosclerosis, 2006
- Does Low-Density Lipoprotein Size Add to Atherogenic Particle Number in Predicting the Risk of Fatal Myocardial Infarction?The American Journal of Cardiology, 2006
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Differential effects of nicotinic acid in subjects with different LDL subclass patternsAtherosclerosis, 1992
- Lipoprotein (a). Heterogeneity and biological relevance.Journal of Clinical Investigation, 1990
- Changes in Plasma Lipids and Lipoproteins in Overweight Men during Weight Loss through Dieting as Compared with ExerciseNew England Journal of Medicine, 1988
- Apolipoprotein E polymorphism in health and diseaseAmerican Heart Journal, 1987
- The Effect of Cessation and Resumption of Moderate Alcohol Intake on Serum High-Density-Lipoprotein SubfractionsNew England Journal of Medicine, 1984
- Atherosclerosis—Relationship to coronary blood flowThe American Journal of Cardiology, 1983